YM BioSciences (YMI) Misses Q2 Views
- Tiffany & Co. (TIF) Tops Q2 EPS by 11c; Boosts FY14 EPS Outlook
- After-Hours Stock Movers 8/26: (TUBE) (CHMT) (ARUN) Higher; (SWHC) (RGR) (TIVO) Lower (more...)
- Yingli Green Energy (YGE) Posts Q2 Loss of 25c/ADS; Guides FY14 Shipments
- Smith & Wesson Holding Corp. (SWHC) Tops Q1 EPS by 1c; Cuts FY15 Outlook
- Express (EXPR) Tops Q2 EPS by 8c; Guides FY14 EPS Above Consensus
YM BioSciences Inc. (NYSE: YMI) reported Q2 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $670 thousand.
You May Also Be Interested In
- Brown-Forman Corp. (BF-B) Misses Q1 EPS by 2c; Reaffirms FY15 Outlook
- Donaldson Co., Inc. (DCI) Tops Q4 EPS by 3c; Guides FY15
- The Michaels Companies (MIK) Tops Q2 EPS by 7c, Sales Beat
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!